Bayern Munich midfielder Jamal Musiala is suffering from treatable absence seizures caused by a neurological dysfunction [1, 2].
The diagnosis explains two recent on-field collapses that have raised concerns regarding the health and availability of one of the club's most vital attacking players.
Musiala experienced two collapses within a four-day span [1, 3]. The most recent incident occurred on Tuesday, Aug. 18, during a friendly match [2]. In that game, Musiala had entered as a substitute and collapsed eight minutes after joining the play [4].
Medical reports indicate the episodes are linked to a neurological dysfunction [2, 5]. Absence seizures are a specific type of seizure that can cause a brief lapse in consciousness, which in this case resulted in physical collapses during high-intensity competition [2].
Club and medical statements describe the condition as treatable [2]. While the specific treatment plan has not been detailed, the classification of the seizures as treatable suggests a path toward management that could allow the player to return to professional competition.
Musiala's absence creates a tactical gap for Bayern Munich as they navigate their current schedule. The frequency of the episodes, occurring twice in less than a week, highlighted the urgency of the medical investigation [1, 3].
“Jamal Musiala is suffering from treatable absence seizures caused by a neurological dysfunction.”
The diagnosis of absence seizures provides a clinical explanation for Musiala's sudden collapses, moving the conversation from acute injury to chronic condition management. Because the condition is labeled as treatable, the focus for Bayern Munich shifts to whether medication or lifestyle adjustments can mitigate the risk of further on-field episodes during the physical demands of professional football.
